Literature DB >> 27570313

Two-Year Follow-up Study of Mycobacterium tuberculosis Antigen-Driven IFN-γ Responses and Macrophage sCD14 Levels After Tuberculosis Contact.

Magdalena Druszczynska1, Marcin Wlodarczyk1, Grzegorz Kielnierowski2, Malwina Kawka1, Wieslawa Rudnicka1.   

Abstract

Clinical data regarding the prediction of active tuberculosis (TB) development in close TB contacts are scarce. To address this problem, we performed a 2-year follow-up study of Mycobacterium tuberculosis (M.tb) antigen-driven IFN-gamma responses and serum levels of soluble macrophage CD14 receptor in individuals with recent or prolonged M.tb exposure. Between June 2011 and June 2013, we studied 60 healthy Polish adults with recent household or long-term work TB contact and individuals without known M.tb exposure. All of them underwent baseline and repeated testing with IGRA (IFN-gamma release assay) and serum sCD14 ELISA quantification. Frequencies of IGRA results differed at the baseline and follow-up testing. IGRA reversions were noticed in almost one-third of Work TB Contacts and no participants from the Household TB Contact group. IGRA conversions were found in 40 % of Household TB Contacts. No correlation between the IGRA result and the sCD14 level was observed. IFN-γ variability has important implications for clinical practice and requires caution in interpreting the results to distinguish new infections from nonspecific inter-individual variations in cytokine responses. The impairment of IFN-γ response in some individuals with prolonged M.tb exposure representing a resistant immune status does not allow considering IGRA results as reliable and credible. Monitoring the serum sCD14 level can reduce the likelihood of a false prediction of active TB development in close TB contacts showing an M.tb-specific increase in the IFN-gamma production in repeated IGRA testing.

Entities:  

Keywords:  Interferon-gamma response; Macrophage sCD14 receptor; Mycobacterium tuberculosis; TB contacts

Year:  2016        PMID: 27570313      PMCID: PMC4984431          DOI: 10.1007/s12088-016-0571-y

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  39 in total

1.  Increased levels of circulating soluble CD14 in Kawasaki disease.

Authors:  S Takeshita; K Nakatani; H Tsujimoto; Y Kawamura; H Kawase; I Sekine
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

2.  Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis.

Authors:  Chloé Wyndham-Thomas; Véronique Corbière; Violette Dirix; Kaatje Smits; Fanny Domont; Myriam Libin; Marc Loyens; Camille Locht; Françoise Mascart
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

Review 3.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

4.  Monthly follow-ups of interferon-γ release assays among health-care workers in contact with patients with TB.

Authors:  Jong Sun Park; Ji Sun Lee; Min Young Kim; Chang Hoon Lee; Ho Il Yoon; Sang-Min Lee; Chul-Gyu Yoo; Young Whan Kim; Sung Koo Han; Jae-Joon Yim
Journal:  Chest       Date:  2012-12       Impact factor: 9.410

5.  Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak.

Authors:  Seung Heon Lee; Woo Jin Lew; Hee Jin Kim; Hyun-Kyung Lee; Young Min Lee; Chong Hee Cho; Eun Joo Lee; Dong Yeol Lee; Sung Weon Ryu; Soo Yeon Oh; Sin Ok Kim; Tae Sun Shim
Journal:  Respir Med       Date:  2009-10-29       Impact factor: 3.415

6.  Prognostic value of a T-cell-based, interferon-gamma biomarker in children with tuberculosis contact.

Authors:  Mustafa Bakir; Kerry A Millington; Ahmet Soysal; Jonathan J Deeks; Serpil Efee; Yasemin Aslan; Davinder P S Dosanjh; Ajit Lalvani
Journal:  Ann Intern Med       Date:  2008-10-20       Impact factor: 25.391

7.  Rapid method for Mycobacterium tuberculosis identification using electrospray ionization tandem mass spectrometry analysis of mycolic acids.

Authors:  Rafał Szewczyk; Konrad Kowalski; Beata Janiszewska-Drobinska; Magdalena Druszczyńska
Journal:  Diagn Microbiol Infect Dis       Date:  2013-05-11       Impact factor: 2.803

8.  CD14 gene promoter polymorphism in different clinical forms of tuberculosis.

Authors:  Eugenia Pacheco; Carolina Fonseca; Carlos Montes; Jovanny Zabaleta; Luis F García; Mauricio A Arias
Journal:  FEMS Immunol Med Microbiol       Date:  2004-04-09

9.  Monocyte signal transduction receptors in active and latent tuberculosis.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Beata Janiszewska-Drobinska; Grzegorz Kielnierowski; Joanna Zawadzka; Magdalena Kowalewicz-Kulbat; Marek Fol; Piotr Szpakowski; Karolina Rudnicka; Magdalena Chmiela; Wieslawa Rudnicka
Journal:  Clin Dev Immunol       Date:  2013-01-20

10.  Interferon-gamma assay in combination with tuberculin skin test are insufficient for the diagnosis of culture-negative pulmonary tuberculosis.

Authors:  Marcin Wlodarczyk; Wieslawa Rudnicka; Beata Janiszewska-Drobinska; Grzegorz Kielnierowski; Magdalena Kowalewicz-Kulbat; Marek Fol; Magdalena Druszczynska
Journal:  PLoS One       Date:  2014-09-15       Impact factor: 3.240

View more
  1 in total

1.  CD14-159C/T polymorphism in the development of delayed skin hypersensitivity to tuberculin.

Authors:  Magdalena Druszczynska; Marcin Wlodarczyk; Grzegorz Kielnierowski; Michal Seweryn; Sebastian Wawrocki; Wieslawa Rudnicka
Journal:  PLoS One       Date:  2017-12-27       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.